Bottom Line Summary
Aspirin for Primary Prevention of Cardiovascular Disease
For patients at low to moderate risk of cardiovascular events, aspirin causes more harm (non-trivial bleeding) than benefit (reduced cardiovascular events) when used for primary prevention. Mortality is not reduced by aspirin over an average of 6 years.
Download PDF